MedPharm’s Post

Don't miss the next Expert Briefing session at the European Parliament "Navigating Diagnostics Through the Lens of the Pharmaceutical Package and Beyond", hosted by MEP Stelios Kympouropoulos, where Prof. Alessandra Ferlini (#Screen4Care), Marie-Christine Ouillade (#SMA Europe), Hélène Leborgne (#europeancommission) and Joshi Venugopal (#Novartis) will share their perspective. Everyone is well aware of the critical role that screening plays in the early identification of - in some cases life-threatening - rare diseases and addressing unmet medical needs. But why does it take so much time to adopt guidelines at EU level? #wewontrest #imagine #rarediseaseday2024 #raredisease #communityhealth #lightupforrare #awareness #INSD #neonatalscreeningmatters #europeanunion #europeanparliament #europeancommission #eu2024be

We are delighted to share with you our new paper “Maximizing the Value of Real‐World Data and Real‐World Evidence to Accelerate Healthcare Transformation in China: Summary of External Advisory Committee Meetings” just published in Pharmaceutical Medicine Journal! Thank you to everyone involved for helping to make this achievement happen. To discover how RWD sources are empowering clinical practice and patient management in China, you can read the manuscript here: https://lnkd.in/eWVFksct

CREATION identified 7,135 eHCP mentions of pharmaceutical companies in March 2024, which was 14% fewer than the previous month. There were three Pharma initiatives that garnered a lot of HCP attention: 1. An Oncologists tutorial on X for #TumorBoardTuesday discussing data revealed at #ESMO2023 gained particular attention by HCPs 2. Dr. Michael Gibson shared the “big news” of Novo Nordisk, Wegovy receiving an expanded label approval from the FDA. The post was shared by 9 HCPs. 3. Six HCPs shared an article diving into the potential of Gilead Sciences’s antiviral treatment “obeldesivir” against Ebola. (Link in the comments) #pharma #healthcare

An excellent paper Carmen Moreno Redondo! Once again real-world data (RWD) is continuing to show promise in improving evidence generation and patient outcomes globally. This paper highlights what we continue to do at Cisiv Ltd, accelerating healthcare transformation by taking a patient-centric approach, which is essential for unlocking RWD's full potential. Add this to your reading list! #realworldevidence #realworlddata #patientoutcomes

Adalvo has submitted its 𝐃𝐂𝐏 𝐟𝐢𝐥𝐢𝐧𝐠 𝐟𝐨𝐫 𝐓𝐞𝐝𝐮𝐠𝐥𝐮𝐭𝐢𝐝𝐞 on Day-1 following the 𝐞𝐱𝐩𝐢𝐫𝐲 𝐨𝐟 𝐃𝐚𝐭𝐚 𝐄𝐱𝐜𝐥𝐮𝐬𝐢𝐯𝐢𝐭𝐲. This submission presents a 𝐟𝐢𝐫𝐬𝐭-𝐭𝐨-𝐦𝐚𝐫𝐤𝐞𝐭 𝐨𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐲 for Adalvo, underscoring our commitment to addressing unmet medical needs in the rare disease segment. With 𝐧𝐨 𝐚𝐥𝐭𝐞𝐫𝐧𝐚𝐭𝐢𝐯𝐞 𝐩𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐜𝐚𝐥 𝐭𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭𝐬 𝐜𝐮𝐫𝐫𝐞𝐧𝐭𝐥𝐲 𝐚𝐯𝐚𝐢𝐥𝐚𝐛𝐥𝐞 𝐟𝐨𝐫 𝐒𝐁𝐒, the wider availability of Teduglutide is highly anticipated. This strategic filing reflects Adalvo’s focus on providing high-value, differentiated products to the market 𝐩𝐫𝐨𝐦𝐩𝐭𝐥𝐲 𝐚𝐧𝐝 𝐞𝐟𝐟𝐢𝐜𝐢𝐞𝐧𝐭𝐥𝐲. Click here to find out more - https://lnkd.in/exNPt6wC #Adalvo #AlwaysOnTarget #Teduglutide #DCPFiling

⏱️ Only 11 months (-1 day) left before EU HTA becomes reality! It is critical that all stakeholders work together to make the implementation a success for patients in Europe. Especially in times where not all is clear yet... 💬 At World Evidence, Pricing and Access Congress we will hold a panel discussion on "EU HTA: How to ensure stakeholder alignment on a national level to accelerate broad patient access?" 👉 Please join Neil Grubert, Mihai Iulian Rotaru (EFPIA - European Federation of Pharmaceutical Industries and Associations), Herbert Altmann (Cencora PharmaLex) and myself (Vintura) in this discussion! 📍 12 March, 12:45 CET Hope to see you there, or at any other moment during the conference. Cencora, Cencora | Pharma solutions

Learn about the shifting roles of CROs ... Our CEO, Penelope Przekop, was one of three industry experts who contributed to this recent article published by World Pharmaceutical Frontiers / Clinical Trials Insights Magazine. Go here to read the article: https://lnkd.in/e4ig-53T (see page 31) #CRO #pharmaindustry #clincialtrials #industryinsights #drugdevelopment #artical

Unpacking the pharmaceutical package: In this episode, Valeria Fagone, Managing Director at FTI Consulting, sat down with Marc Dooms, Senior Orphan Drug Pharmacist at University Hospitals Leuven in Belgium, to discuss how the revisions within the EU Pharma Package will impact patients' ability to access care and information. Tune into our episode to hear more as we unpack the pharma package together! https://lnkd.in/eKyHrEEc

Check out this great article on the shifting roles of CROs. I was honored to contribute my thoughts and opinions on the topic along with two other industry experts. After reading it, let me know what your thoughts are on the topic.

With compliments of the IFAPP - International Federation of Associations of Pharmaceutical Physicians & Pharmaceutical Medicine - Communication Working Group, you can read here the first edition of IFAPP TODAY of 2024! Great contributions from and about: - President's New Year Message - Discover the Future of Digital Health in Africa - Summary of the 28th Swiss Annual Symposium inPharmaceutical Medicine on 29th November 2023 - Successful Completion of the First EUPATI CH Course on Patient Involvement in Clinical Research - AMIFE Talks about Precision Medicine on its Congress - AI in Pharmacovigilance - Report from the IFAPP Webinar on 30 November 2023 - Symposium on Antibiotic Resistance - IFAPP Free Webinar: The Future of Clinical Trials, the Promise of AI and Key Trends #pharmaceuticalmedicine #clintrials #clinresearch #